Nerses Antaplyan v. Transamerica Premier Life Insurance Company

CourtDistrict Court, C.D. California
DecidedFebruary 22, 2023
Docket2:22-cv-08117
StatusUnknown

This text of Nerses Antaplyan v. Transamerica Premier Life Insurance Company (Nerses Antaplyan v. Transamerica Premier Life Insurance Company) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nerses Antaplyan v. Transamerica Premier Life Insurance Company, (C.D. Cal. 2023).

Opinion

Case 2:22-cv-08117-GW-JEM Document 32 Filed 02/22/23 Page 1 of 14 Page ID #:135

1 ROBERT S. GIANELLI #82116 JOSHUA S. DAVIS #193187 2 ALEXANDRA H. GIANELLI #324246 3 GIANELLI & MORRIS, A Law Corporation 550 South Hope Street, Suite 1645 4 Los Angeles, CA 90071 5 Tel: (213) 489-1600; Fax: (213) 489-1611 rob.gianelli@gmlawyers.com 6 joshua.davis@gmlawyers.com 7 alex.gianelli@gmlawyers.com

8 Attorneys for Plaintiffs 9 NERSES ANTAPLYAN; SARKIS CHRISTOPHER ANTAPLYAN; JAMES ZOHRAB ANTAPLYAN; 10 NICHOLAS ANDREW ANTAPLYAN

11 [Additional Counsel Listed on Signature Page]

13 UNITED STATES DISTRICT COURT

14 CENTRAL DISTRICT OF CALIFORNIA 15 NERSES ANTAPLYAN; SARKIS Case No. 2:22-cv-08117 GW (JEMx) 16 CHRISTOPHER ANTAPLYAN; JAMES 17 ZOHRAB ANTAPLYAN; NICHOLAS Honorable John E. McDermott ANDREW ANTAPLYAN, United States Magistrate Judge 18

19 Plaintiffs, STIPULATED PROTECTIVE ORDER 20 v. 21 Complaint Filed: Nov. 07, 2022 TRANSAMERICA PREMIER LIFE 22 INSURANCE COMPANY, 23 Defendant. 24

26 27 28 1 Case 2:22-cv-08117-GW-JEM Document 32 Filed 02/22/23 Page 2 of 14 Page ID #:136

1 Subject to the approval of this Court, Plaintiffs Nerses Antaplyan, Sarkis 2 Christopher Antaplyan, James Zohrab Antaplyan, and Nicholas Andrew Antaplyan 3 and Defendant Transamerica Premier Life Insurance Company (collectively, the 4 “Parties”), by and through their respective counsel of record, hereby stipulate to the 5 following protective order: 6 1. A. PURPOSES AND LIMITATIONS 7 Disclosure and discovery in this Action are likely to involve production of 8 confidential, proprietary, or private information for which special protection from 9 public disclosure and from use for any purpose other than prosecuting this Action 10 may be warranted. Accordingly, the Parties hereby stipulate to and petition the Court 11 to enter the following Stipulated Protective Order (“Order”). The Parties 12 acknowledge that this Order does not confer blanket protections on all disclosures or 13 responses to discovery and that the protection it affords from public disclosure and 14 use extends only to the limited information or items that are entitled to confidential 15 treatment under the applicable legal principles. The Parties further acknowledge, as 16 set forth in Paragraph 4, below, that this Stipulated Protective Order does not entitle 17 them to file confidential information under seal; Civil Local Rule 79-5 sets forth the 18 procedures that must be followed and the standards that will be applied when a party 19 seeks permission from the Court to file material under seal. Nothing in this order 20 shall limit the testimony of Parties or non-parties, or the use of certain documents, at 21 any court hearing or trial. Such determinations will only be made by the Court at the 22 hearing or trial, or upon an appropriate motion. 23 B. GOOD CAUSE STATEMENT 24 The Parties acknowledge that information produced in discovery, regardless of 25 its designation under this Order, may contain personally identifiable information or 26 health information subject to the protections of, inter alia, the Health Insurance 27 Portability and Accountability Act of 1996, the applicable requirements of the 28 Standards for Privacy of Individually Identifiable Health Information and its 2 Case 2:22-cv-08117-GW-JEM Document 32 Filed 02/22/23 Page 3 of 14 Page ID #:137

1 implementing regulations issued by the U.S. Department of Health and Human 2 Services (45 C.F.R. Parts 160-64; HIPAA Privacy Regulations), and California Civil 3 Code §§ 56 et seq., and 1798.82 et seq., which protect the confidentiality of 4 personally identifiable personal and health information. Discovery may also involve 5 trade secrets, customer and pricing lists and other valuable research, development, 6 commercial, financial, technical and/or proprietary information for which special 7 protection from public disclosure and from use for any purpose other than prosecution 8 of this Action is warranted. 9 Accordingly, to expedite the flow of information, to facilitate the prompt 10 resolution of disputes over confidentiality of discovery materials, to adequately 11 protect information the Parties are entitled or required to keep confidential, to ensure 12 that the Parties are permitted reasonably necessary uses of such material in 13 preparation for and in the conduct of trial, to address their handling at the end of the 14 Action, and to serve the ends of justice, a protective order for such information is 15 justified in this matter. It is the intent of the Parties that information will not be 16 designated as confidential for tactical reasons and that nothing be so designated 17 without a good faith belief that it has been maintained in a confidential, non-public 18 manner, and there is good cause why it should not be part of the public record of this 19 case. 20 2. DEFINITIONS 21 2.1 Acknowledgement: The “Acknowledgement and Agreement to be 22 Bound” form attached to this Order as Exhibit A. 23 2.2 Action: Nerses Antaplyan, et al. v. Transamerica Premier Life 24 Insurance Company, Case No. 2:22-cv-08117 GW (JEMx). 25 2.3 Challenging Party: A party or non-party that challenges the 26 designation of information or items under this Order. 27 28 3 Case 2:22-cv-08117-GW-JEM Document 32 Filed 02/22/23 Page 4 of 14 Page ID #:138

1 2.4 Designating Party: A party or non-party that designates information or 2 items that it produces or that are produced in disclosures or in response to discovery 3 as “CONFIDENTIAL.” 4 2.5 Party: Any party to this Action, including its officers, directors, 5 employees, consultants, retained experts, in-house counsel, and outside counsel of 6 record (and their respective support staff). 7 2.6 Producing Party: A Party or non-party that discloses or produces 8 information in this Action. 9 2.7 Receiving Party: A Party that receives information from a Producing 10 Party. 11 3. DESIGNATION OF “CONFIDENTIAL MATERIAL” 12 3.1 For purposes of this Stipulated Protective Order, “Confidential 13 Material” includes the following types of documents and information: 14 a. information that is proprietary or constitutes a trade secret, 15 including, without limitation, information, materials, and other documents reflecting 16 non-public business or financial strategies and confidential competitive information 17 that, if disclosed, could result in prejudice or harm to the disclosing party; 18 b. non-public financial or business information; 19 c. information that is otherwise generally unavailable to the public; 20 d. policyholder-specific information, including private medical 21 information of the policyholder or third parties. 22 3.2 Any copies or reproductions, excerpts, summaries, or other documents 23 or media that contain or incorporate Confidential Material as defined above will also 24 be treated as Confidential Material under this Order. 25 3.3 Nothing in this Stipulated Protective Order will be construed as 26 requiring Defendant to produce any personal or identifying information regarding any 27 individual or any other policyholder, nor policyholder information that is protected 28 from disclosure under applicable state or federal law. 4 Case 2:22-cv-08117-GW-JEM Document 32 Filed 02/22/23 Page 5 of 14 Page ID #:139

1 3.4 A Party or nonparty may designate documents or information as 2 “Confidential Material” as follows: 3 a. In the case of documents and information contained in 4 documents, designation must be made by prominently placing the following legend 5 on each page of the document before production: 6 “CONFIDENTIAL SUBJECT TO PROTECTIVE ORDER” OR 7 “CONFIDENTIAL”

8 b.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Nerses Antaplyan v. Transamerica Premier Life Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nerses-antaplyan-v-transamerica-premier-life-insurance-company-cacd-2023.